Entera Bio Ltd (NASDAQ:ENTX)
| 1.33 Delayed Data As of 3:59pm ET |  -0.18 / -11.92%Today’s Change | 1.32 Today|||52-Week Range 6.60 | -52.75% Year-to-Date |
Latest ENTX News | Press Releases
No recent news for Entera Bio Ltd.
Today’s Trading
| Previous close | 1.51 |
| Today’s open | 1.42 |
| Day’s range | 1.32 - 1.42 |
| Volume | 948 |
| Average volume (3 months) | 36,156 |
| Market cap | $50.1M |
Data as of 3:59pm ET, 06/29/2022
Growth & Valuation
| Earnings growth (last year) | +13.97% |
| Earnings growth (this year) | -50.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +56.44% |
| P/E ratio | NM |
| Price/Sales | 128.84 |
| Price/Book | 2.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MBRXMoleculin Biotech In... | +0.05 | +3.45% |
| AIMAIM ImmunoTech Inc | -0.01 | -1.19% |
| TCONTRACON Pharmaceutica... | -0.01 | -0.50% |
| CASICASI Pharmaceuticals... | -0.10 | -3.37% |
Data as of 3:59pm ET, 06/29/2022
Financials
| Next reporting date | August 24, 2022 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $571.0K |
| Annual profit (last year) | -$12.2M |
| Net profit margin | -2,134.33% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Jerusalem, Jerusalem |
Forecasts
